Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Helen F. Graham Cancer Center
& Research Institute

Gynecologic Oncology

The Helen F. Graham Cancer Center & Research Institute’s Division of Gynecologic Oncology is a dedicated group of medical professionals with expertise in the diagnosis and treatment of gynecologic cancers. Treatment options available to our patients include standard approaches such as surgery — including da Vinci robotic surgery—chemotherapy and radiation, as well as the very latest clinical trials available through our association with the National Cancer Institute’s Gynecologic Oncology Group.

We understand how frightening the diagnosis of gynecologic cancer can be. As we take care of your medical needs, we will also help you address any related physical or emotional issues that you and your loved ones may face. We will never lose focus on your quality of life as we work toward curing you of this disease.

cancer infusion suite

The infusion suite at the Division of Gynecologic Oncology overlooks the gardens and fountains behind the Helen F. Graham Cancer Center & Research Institute.

The importance of a gynecologic oncologist in your battle against cancer

Our gynecologic oncologists are specially trained to care for women with gynecologic cancers such as cervical cancer, endometrial or uterine cancer, and ovarian cancer. Because these cancers are complex, and treatment can involve multiple modalities, it is important to be sure that the doctor managing your care is experienced and highly trained specifically in treating gynecologic cancer.

Our gynecologic multidisciplinary team specializes in treating cancers of the ovary, endometrium, uterus, cervix, vagina and vulva. Decades of clinical experience show that combinations of surgery, chemotherapy and radiation are most effective in treating gynecologic cancers. However, this clinical experience has also brought to light our need to tailor your care both in terms of the disease itself and its overall effect on you.

Division of Gynecologic Oncology
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4285